SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Four FDA submissions ++

<< Previous

Bullboard Posts

Next >>

Comment by Lennocon Apr 30, 2021 6:14pm

132 Views

Post# 33106430

RE:Four FDA submissions ++

Factfinder, I agree. The M/C is too low along with the share price. I have picked up a few shares down here but I would like to see the share price reflect the true value of the company. I sure once we get a few FDA approvals the share price will double.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing